GRAIL logo

Sr. Cost Accountant #5010

GRAIL

Durham, NC; Sunnyvale, CAHybridPosted 1 day ago$94,000 - $144,000/year
Full TimeSenior LevelCorporate FunctionsBiotechnology
Original posting ↗

Summary

The Senior Cost Accountant is a key contributor to the Finance organization, primarily supporting the Cost Accounting department with day-to-day inventory and cost of goods sold (COGS) activities. This role requires an accounting professional with experience in a fast-paced private or public life sciences company who has demonstrated the ability to support accounting operations and meet the evolving needs of a growing business.

Job description

Responsibilities

  • Perform month-end and quarter-end SOX-compliant financial close processes related to cost of goods sold and inventory.
  • Prepare detailed calculations for inventory, cost of goods sold, inventory reserves, and overhead allocations.
  • Prepare detailed account analyses and reconciliations for respective general ledger (GL) accounts.
  • Perform fluctuation analyses and product cost calculations.
  • Assist in resolving inventory-related and system inquiries.
  • Support quarterly financial reviews and annual audits.
  • Assist with product costing and financial analyses.
  • Support and maintain strong internal control processes.
  • Assist in preparing cycle count and annual inventory audit reconciliations.
  • Collaborate with the Lab and FP&A teams to develop processes and procedures, ensure the accuracy and completeness of inventory data, and implement changes as needed.
  • Support ERP system enhancements and process improvement projects.

Required Qualifications

  • Bachelor's degree (BS/BA) in Finance, Accounting, Business, or a related field
  • 5+ years of accounting experience including work in a SOX-compliant environment.
  • Demonstrated teamwork and collaboration skills.
  • Ability to prioritize assignments, manage interruptions, and meet deadlines in a fast-paced, growth-oriented environment.
  • Excellent professional written and verbal communication and interpersonal skills.
  • Strong analytical and project management skills.
  • Demonstrated logical reasoning and critical thinking skills.

Preferred Qualifications

  • Audit experience preferred.
  • Experience in a manufacturing or life sciences company.
  • Experience with NetSuite and Google Workspace.

Requirements

  • Bachelor's degree (BS/BA) in Finance, Accounting, Business, or a related field
  • 5+ years of accounting experience including work in a SOX-compliant environment
  • Demonstrated teamwork and collaboration skills
  • Ability to prioritize assignments, manage interruptions, and meet deadlines in a fast-paced, growth-oriented environment
  • Excellent professional written and verbal communication and interpersonal skills
  • Strong analytical and project management skills
  • Demonstrated logical reasoning and critical thinking skills
  • Audit experience preferred
  • Experience in a manufacturing or life sciences company
  • Experience with NetSuite and Google Workspace

Benefits

  • Flexible time off
  • Vacation
  • 401(k) retirement plan
  • Employer match
  • Medical coverage
  • Dental coverage
  • Vision coverage
  • Well-being programs

Company overview

GRAIL, Inc. is an American biotechnology company headquartered in Menlo Park, California, founded in 2015 with a mission to detect cancer early when it can be cured. The company specializes in developing multi-cancer early detection (MCED) tests using advanced liquid biopsy technology. GRAIL's flagship product, the Galleri test, is a blood-based screening test that aims to identify multiple cancer types before symptoms appear, including many deadly cancers that currently lack recommended screening methods. The company leverages next-generation sequencing, population-scale clinical studies, and sophisticated machine learning algorithms to analyze cell-free DNA methylation patterns in blood samples. With approximately 1,000 employees and operations in the United States and United Kingdom, GRAIL has conducted extensive clinical trials including the NHS-Galleri trial in England. The company was originally a subsidiary of Illumina before being spun off as an independent public company trading on Nasdaq under the ticker GRAL in 2024.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.